Merck Buy Hold or Sell Recommendation

MRK -- USA Stock  

Earning Report: October 29, 2019  

Considering 30-days investment horizon, and your above average risk tolerance our recommendation regarding Merck Company is 'Strong Hold'. Macroaxis provides Merck buy hold or sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding Merck positions. The advice algorithm takes into account all of Merck available fundamental, technical, and predictive indicators you will find on this site. The advice is provided from Merck buy-and-hold prospective. Please see also Merck Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for muliple equity instruments please use Instant Ratings tool.

Time Horizon

Risk Tolerance

Execute Advice
Sell MerckBuy Merck
Strong Hold


Hype Condition

Current Valuation

Odds of Distress

Economic Sensitivity

Analyst Consensus

Piotroski F Score

Financial Leverage

For the selected time horizon Merck Company has a risk adjusted performance of 0.0098, jensen alpha of 0.0179, total risk alpha of 0.0347, sortino ratio of 0.0175 and treynor ratio of (0.00037686)
Macroaxis provides buy or sell recommendations on Merck to complement and cross-verify current analyst consensus on Merck. Our advice engine determines the firm potential to grow exclusively from the prospective of investors current risk tolerance and investing horizon. To make sure Merck is not overpriced, please verify all Merck Company fundamentals including its Revenue, Cash Flow from Operations, Current Asset, as well as the relationship between Cash per Share and Beta . Given that Merck has Price to Earning of 23.52 , we recommend you check Merck market performance and probability of bankruptcy to make sure the company can sustain itself in the current economic cycle given your last-minute risk tolerance and investing horizon.

Merck Trading Alerts and Improvement Suggestions

Merck has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial commitments
Over 78.0% of the company shares are owned by institutional investors
Latest headline from US STOCKS-SP 500 rises on upbeat corporate earnings Travelers weighs on Dow - Reuters

Merck current analysts recommendations

Target Median Price95.50
Target Mean Price96.36
Recommendation Mean1.70
Target High Price105.00
Number Of Analyst Opinions14
Target Low Price89.00

Merck Returns Distribution Density

Mean Return0.009745Value At Risk2.38
Potential Upside1.51Standard Deviation1.28
 Return Density 

Institutional Investors

Security TypeSharesValue
Robeco Institutional Asset Management BvCommon Shares3.9 M332.3 M
Pggm InvestmentsCommon Shares2.6 M215.6 M
Cibc Private Wealth Group LlcCommon Shares2.3 M194.2 M
Davenport Co Llc 1Common Shares1.7 M146.1 M
Envestnet Asset Management IncCommon Shares1.4 M117 M
Zurcher Kantonalbank Zurich CantonalbankCommon Shares1.4 M113.9 M
Gateway Investment Advisers LlcCommon Shares1.2 M104.1 M
Simplex Trading LlcPut Options7.6 K64.2 M
Simplex Trading LlcCall Options6.9 K58.3 M

Merck Greeks

Alpha over DOW
Beta against DOW=0.68
Overall volatility
Information ratio =0.0208

Merck Volatility Alert

Merck Company has relatively low volatility with skewness of -0.88 and kurtosis of 1.16. However, we advise all investors to independently investigate Merck Company to ensure market all accessible information is consistent with the expectations about its upside potential and future risk-adjusted return.
 Better Than Average     
 Worse Than Average Compare Merck to competition

Merck Fundamental Vs Peers

FundamentalsMerckPeer Average
Return On Equity0.29 (0.31) 
Return On Asset0.13 (0.14) 
Profit Margin0.18 (1.27) 
Operating Margin38.73 (5.51) 
Current Valuation233.35 B16.62 B
Shares Outstanding2.56 B571.82 M
Shares Owned by Insiders0.08 10.09 
Shares Owned by Institutions78.28 39.21 
Number of Shares Shorted21.47 M4.71 M
Price to Earning23.52 28.72 
Price to Book7.79 9.51 
Price to Sales4.84 11.42 
Revenue44.37 B9.43 B
Gross Profit28.81 B27.38 B
EBITDA17.18 B3.9 B
Net Income9.36 B570.98 M
Cash and Equivalents7.1 B2.7 B
Cash per Share2.78 5.01 
Total Debt27.59 B5.32 B
Debt to Equity99.40 48.70 
Current Ratio1.21 2.16 
Book Value Per Share9.89 1.93 K
Cash Flow from Operations9.63 B971.22 M
Short Ratio2.41 4.00 
Earnings Per Share3.57 3.12 
Price to Earnings To Growth1.96 4.89 
Number of Employees69 K18.84 K
Market Capitalization214.76 B19.03 B
Total Asset101.78 B29.47 B
Retained Earnings29.54 B9.33 B
Working Capital10.56 B1.48 B
Current Asset29.76 B9.34 B
   Acquisition by Patricia Russo of 2095 shares of Merck subject to Rule 16b-3 [view details]

Merck Market Momentum